v3.25.2
Stock-Based Compensation
6 Months Ended
Aug. 02, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

(12) Stock-Based Compensation

Stock-Based Compensation

During the 13 and 26 weeks ended August 2, 2025, the Company recognized total stock-based compensation expense of $827 and $1,620, respectively. During the 13 and 26 weeks ended August 3, 2024, the Company recognized total stock-based compensation expense of $1,217 and $2,391, respectively. Compensation expense related to the Company’s stock-based payment awards is recognized in selling, general, and administrative expenses in the condensed consolidated statements of operations.

Employee Stock Plan

As of August 2, 2025, the number of shares available for awards under the Amended and Restated 2019 Performance Incentive Plan (as amended and restated, the “Amended 2019 Plan”) was 1,653. As of August 2, 2025, there were 2,243 unvested stock awards outstanding under the 2019 Plan.

Employee Stock Purchase Plan

The Company also maintains an Amended and Restated Employee Stock Purchase Plan (the “ESPP”) that was approved by the Company’s stockholders in fiscal year 2015, under which 1,600 shares of common stock were authorized. During the 13 weeks ended August 2, 2025, 43 shares were issued under the ESPP and, as of August 2, 2025, the number of shares available for issuance was 728.

Nonvested Performance-Based Stock Awards

During the 13 and 26 weeks ended August 2, 2025, the Company did not issue any nonvested performance-based stock awards to employees.

During the 13 weeks ended August 3, 2024, the Company did not issue any nonvested performance-based stock awards to employees. During the 26 weeks ended August 3, 2024, the Company issued 874 nonvested performance-based stock awards to employees at a weighted average grant date fair value of $3.09 per share. The nonvested performance-based stock awards issued to employees vest in full on the third anniversary of the grant date. The number of shares issued was contingent on management achieving a fiscal year 2024 performance target for earnings before interest, taxes, depreciation and amortization expenses. If a minimum threshold performance target is not achieved, no shares would vest. The maximum number of shares subject to the award was 874. Following the

end of the performance period for fiscal year 2024, the fiscal year performance targets were not met and all shares were forfeited as of February 1, 2025.

The following table sets forth the rollforward of outstanding nonvested performance-based stock awards (per share amounts are not in thousands):

 

 

 

 

 

Weighted

 

 

 

 

 

average

 

 

 

 

 

grant-date

 

 

Shares

 

 

fair value

 

Balance at February 1, 2025

 

 

12

 

 

$

8.40

 

Grants

 

 

 

 

 

 

Forfeitures

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Balance at August 2, 2025

 

 

12

 

 

$

8.40

 

 

 

 

 

 

Weighted

 

 

 

 

 

average

 

 

 

 

 

grant-date

 

 

Shares

 

 

fair value

 

Balance at February 3, 2024

 

 

30

 

 

$

9.03

 

Grants

 

 

874

 

 

 

3.09

 

Forfeitures

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Balance at August 3, 2024

 

 

904

 

 

$

3.29

 

 

Nonvested Stock Unit Awards

During the 13 and 26 weeks ended August 2, 2025, the Company issued 314 and 1,149 nonvested stock units to employees and directors at a weighted average grant date fair value of $1.96 and $1.28 per share, respectively. The shares issued to employees of the Company vest over a three-year period with one third of the shares vesting on each anniversary of the grant date. The shares issued to directors of the Company vest over a 12-month period with one-twelfth of the shares vesting each month.

During the 13 and 26 weeks ended August 3, 2024, the Company issued 267 and 1354 nonvested stock units to employees and directors at a weighted average grant date fair value of $3.18 and $3.12 per share, respectively. The shares issued to employees of the Company vest over a three-year period with one third of the shares vesting on each anniversary of the grant date. The shares issued to directors of the Company vest over a 12-month period with one-twelfth of the shares vesting each month.

The following table sets forth the rollforward of outstanding nonvested stock units (per share amounts are not in thousands):

 

 

 

 

 

Weighted

 

 

 

 

 

average

 

 

 

 

 

grant-date

 

 

Shares

 

 

fair value

 

Balance at February 1, 2025

 

 

1,700

 

 

$

4.01

 

Grants

 

 

1,149

 

 

 

1.28

 

Forfeitures

 

 

(34

)

 

 

4.97

 

Vested

 

 

(584

)

 

 

4.20

 

Balance at August 2, 2025

 

 

2,231

 

 

$

2.57

 

 

 

 

 

 

Weighted

 

 

 

 

 

average

 

 

 

 

 

grant-date

 

 

Shares

 

 

fair value

 

Balance at February 3, 2024

 

 

1,058

 

 

$

7.13

 

Grants

 

 

1,354

 

 

 

3.12

 

Forfeitures

 

 

(43

)

 

 

7.69

 

Vested

 

 

(232

)

 

 

7.59

 

Balance at August 3, 2024

 

 

2,137

 

 

$

4.51